T-Therapeutics

Series-A
t-therapeutics.com Biotech & Healthcare 51-100
Total Funding $150M
Latest Round $91M Series-A
Last Announced Nov 13, 2025
Investors 9 Backers
Decision Makers 6 Verified

About T-Therapeutics

Unleashing the power of natural T cells to reshape the clinical landscape for cancer patients

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Team Size 51-100
Tracked Since Oct 23, 2026

Web & Domain Identity

Official Website t-therapeutics.com
Domain Registered Date Apr 26, 2022

Social & Network Presence

X / Twitter Profile @companies
LinkedIn Corporate Company Profile

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $91,000,000 · Series-A

    Backed by Business Growth Fund, Cambridge Enterprise Ventures

  2. Capital Raise

    Raised $59,000,000 · Series-A

    Backed by Cambridge Innovation Capital, Digitalis Ventures

  3. Milestone

    Website domain registered

    t-therapeutics.com

Investors & Backers

9
Business Growth Fund
Cambridge Enterprise Ventures
Cambridge Innovation Capital
Digitalis Ventures
F-Prime Capital
Sanofi Ventures
Sofinnova Partners
Tencent
University of Cambridge Enterprise

Funding History

2 Rounds
Series-A equity · Nov 13, 2025

Round backers: Business Growth Fund, Cambridge Enterprise Ventures, Cambridge Innovation Capital, Digitalis Ventures, F-Prime Capital, Sanofi Ventures, Sofinnova Partners, Tencent

Series-A equity · Nov 15, 2023

Round backers: Cambridge Innovation Capital, Digitalis Ventures, F-Prime Capital, Sofinnova Partners, Sanofi Ventures, University of Cambridge Enterprise

$59,000,000 bioworld.com

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts